返回 Agenda
Session 17: The FDA and Risk Management
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Pre-Marketing Risk Assessment
- Post-Marketing Risk Assessment
- Risk Evaluation and Mitigation Strategies (REMS)